Aurobindo Pharma U.S.A., Inc. v. ASTRAZENECA AB > Summary
Court Case Number IPR2016-01117
Filing Date Jun 2, 2016
Institution Decision Date Oct 21, 2016
Decision Date Oct 21, 2016
Court Patent Trial and Appeal Board
Status FWD Entered
Administrative JudgesRama G. Elluru, Christopher G. Paulraj, Michael P. Tierney
Judge Writing the Final DecisionRama G. Elluru
Claims Challenged in the Petition: 1, 2, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 25, 26, 27, 28, 29, 30, 32, 33, 34, 35, 36, 37, 39, 40, 41, 42
Claims Instituted: 1, 2, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 25, 26, 27, 28, 29, 30, 32, 33, 34, 35, 36, 37, 39, 40, 41, 42
Petitioner
Patent Owner
Petitioner Attorneys
7Aurobindo Pharma USA
Attorney Name: Gary J. Speier Jr.
Carlson Caspers Vandenburgh & Lindquist, PA.
Aurobindo Pharma USA
Attorney Name: Patrick C. Gallagher
Duane Morris LLP
Aurobindo Pharma USA
Attorney Name: Richard L. Torczon Jr.
Wilson Sonsini Goodrich & Rosati
Aurobindo Pharma USA
Attorney Name: Steven W. Parmelee
Wilson Sonsini Goodrich & Rosati
Aurobindo Pharma USA
Attorney Name: George C. Yu
ArentFox Schiff
Aurobindo Pharma USA
Attorney Name: Sailesh K. Patel
ArentFox Schiff
Patent Owner Attorneys
6AstraZeneca
Attorney Name: Eric E. Grondahl
McCarter & English
AstraZeneca
Attorney Name: Anthony A. Hartmann
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: John H. Livingston
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: David Weingarten
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: John D. Livingstone
Finnegan, Henderson, Farabow, Garrett & Dunner
Related Patents
Doc No | Title | Issue date |
---|---|---|
RE044186 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method | Apr 30, 2013 |